Metformin for antipsychotic-related weight gain and metabolic abnormalities: when, for whom, and for how long?

Am J Psychiatry. 2013 Sep;170(9):947-52. doi: 10.1176/appi.ajp.2013.13060771.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antipsychotic Agents / adverse effects*
  • Female
  • Humans
  • Male
  • Metabolic Diseases / drug therapy*
  • Metformin*
  • Obesity / drug therapy*
  • Psychotic Disorders*
  • Schizophrenia*
  • Weight Gain / drug effects*

Substances

  • Antipsychotic Agents
  • Metformin